Ute Warnecke‐Eberz
About
In The Last Decade
Ute Warnecke‐Eberz
54 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 675
- Surgery 486
- Oncology 426
- Pulmonary and Respiratory Medicine 392
- Cancer Research 317
Countries citing papers authored by Ute Warnecke‐Eberz
This map shows the geographic impact of Ute Warnecke‐Eberz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute Warnecke‐Eberz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute Warnecke‐Eberz more than expected).
Fields of papers citing papers by Ute Warnecke‐Eberz
This network shows the impact of papers produced by Ute Warnecke‐Eberz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute Warnecke‐Eberz. The network helps show where Ute Warnecke‐Eberz may publish in the future.
Co-authorship network of co-authors of Ute Warnecke‐Eberz
This figure shows the co-authorship network connecting the top 25 collaborators of Ute Warnecke‐Eberz. A scholar is included among the top collaborators of Ute Warnecke‐Eberz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute Warnecke‐Eberz. Ute Warnecke‐Eberz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 12 | |
| 3 | 4 | |
| 4 | 30 | |
| 5 | 59 | |
| 6 | 9 | |
| 7 | 15 | |
| 8 | 20 | |
| 9 | 24 | |
| 10 | 13 | |
| 11 | 2 | |
| 12 | 11 | |
| 13 | 33 | |
| 14 | Down-regulation of Gadd45 expression is associated with tumor differentiation in non-small cell lung cancer. | 28 |
| 15 | 8 | |
| 16 | 27 | |
| 17 | 52 | |
| 18 | 39 | |
| 19 | 105 | |
| 20 | 64 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.